CLINICAL_TRIALS trial_result · 2023-07-03

Clinical Trial Update: Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetics [NA]

A completed clinical trial evaluating short messaging service (SMS) to optimize HbA1c management in adults with diabetes; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Campbell University, Incorporated | Conditions: Diabetes | NA | Status: COMPLETED | Results posted: 2023-07-03